semaglutide colon cancer GLP-1 drugs linked to dramatically lower death rates in patients Emerging Evidence Positions GLP-1 Receptor

Inoue, N., Sugihara, F

and risk of dehydration and kidney problems with persistent gastrointestinal symptoms

What we know about weight loss One of the most familiar effects of GLP-1 medications is weight loss, and that may matter for some people with breast cancer

Both medication classes can affect gastrointestinal function, and combining them may potentially amplify certain side effects, particularly nausea and gastrointestinal upset

A key factor supporting market growth is the expansion of digital healthcare platforms and pharmacy logistics networks that enable direct-to-patient delivery of temperature-sensitive injectable medications